Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium (Q38132253)

29 August 2017

title

Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium (English)

1 reference

29 August 2017

0 references

0 references

1 reference

Maria Cecilia Scimia

1

1 reference

29 August 2017

Alessandro Cannavo

series ordinal

2

1 reference

29 August 2017

Walter J Koch

series ordinal

3

1 reference

29 August 2017

publication date

1 August 2013

1 reference

Expert Review of Cardiovascular Therapy

29 August 2017

published in

1 reference

29 August 2017

volume

11

1 reference

29 August 2017

issue

8

1 reference

29 August 2017

page(s)

999-1013

1 reference

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Gene therapy clinical trials worldwide to 2012 - an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

A prospective, single-blind, multicenter, dose escalation study of intracoronary iNOS lipoplex (CAR-MP583) gene therapy for the prevention of restenosis in patients with de novo or restenotic coronary artery lesion (REGENT I extension).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Executive Summary: Heart Disease and Stroke Statistics--2012 Update: A Report From the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

The effect of selective breeding on the development of coronary atherosclerosis in WHHL rabbits. An animal model for familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Intravenous gene therapy for familial hypercholesterolemia using ligand-facilitated transfer of a liposome:LDL receptor gene complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Effect of vascular endothelial growth factor gene transfer on infarct size, left ventricular function and myocardial perfusion in sheep after 2 months of coronary artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Entrance in mitosis of adult cardiomyocytes in ischemic pig hearts after plasmid-mediated rhVEGF165 gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Effects of intramyocardial pVEGF165 delivery on regional myocardial blood flow: evidence for a spatial 'delivery-efficacy' mismatch

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Plasmid-mediated VEGF gene transfer induces cardiomyogenesis and reduces myocardial infarct size in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Gene therapy in cardiac surgery: intramyocardial injection of naked plasmid DNA for chronic myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Adenoviral gene transfer of FGF-5 to hibernating myocardium improves function and stimulates myocytes to hypertrophy and reenter the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Myocardial transfection with naked DNA plasmid encoding hepatocyte growth factor prevents the progression of heart failure in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Augmentation of left ventricular mechanics by recirculation-mediated AAV2/1-SERCA2a gene delivery in experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Type 1 phosphatase, a negative regulator of cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

PKC-alpha regulates cardiac contractility and propensity toward heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Cardiac adenoviral S100A1 gene delivery rescues failing myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Phospholamban: a crucial regulator of cardiac contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Phospholamban overexpression in transgenic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Adenovirus-based phospholamban antisense expression as a novel approach to improve cardiac contractile dysfunction: comparison of a constitutive viral versus an endothelin-1-responsive cardiac promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Comparative analysis of parvalbumin and SERCA2a cardiac myocyte gene transfer in a large animal model of diastolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

A comparative analysis of parvalbumin expression in pinfish (Lagodon rhomboides) and toadfish (Opsanus sp.).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Parvalbumin gene transfer corrects diastolic dysfunction in diseased cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Cardiac-directed parvalbumin transgene expression in mice shows marked heart rate dependence of delayed Ca2+ buffering action

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Noncanonical EF-hand motif strategically delays Ca2+ buffering to enhance cardiac performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Thin filament disinhibition by restrictive cardiomyopathy mutant R193H troponin I induces Ca2+-independent mechanical tone and acute myocyte remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Beta-adrenoceptors in cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Level of G protein–Coupled Receptor Kinase-2 Determines Myocardial Ischemia/Reperfusion Injury via Pro- and Anti-Apoptotic Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

beta2 adrenoceptor gene therapy ameliorates left ventricular dysfunction following cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

The molecular basis for distinct beta-adrenergic receptor subtype actions in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Gene therapy strategies for cardiac electrical dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Molecular ablation of ventricular tachycardia after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Selective molecular potassium channel blockade prevents atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

SERCA2a gene transfer decreases sarcoplasmic reticulum calcium leak and reduces ventricular arrhythmias in a model of chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Targeted sarcoplasmic reticulum Ca2+ ATPase 2a gene delivery to restore electrical stability in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Heart repair by reprogramming non-myocytes with cardiac transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

New efficient catheter-based system for myocardial gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Targeted high-efficiency, homogeneous myocardial gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

21 January 2018

Myocardial gene transfer

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

MCARD-mediated gene transfer of GRK2 inhibitor in ovine model of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Overexpression of p53 increases lumen size and blocks neointima formation in porcine interposition vein grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Ex vivo gene transfer of basic fibroblast growth factor improves cardiac function and blood flow in a swine chronic myocardial ischemia model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Myocarditis following adeno-associated viral gene expression of human soluble TNF receptor (TNFRII-Fc) in baboon hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Non-viral vectors for gene therapy: clinical trials in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

High-efficiency endovascular gene delivery via therapeutic ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Tumor targeting using anti-her2 immunoliposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Development of anti-p185HER2 immunoliposomes for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Current trends in the application of nanoparticles in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Antibody-targeted liposomes in cancer therapy and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Targeting the heart with gene therapy-optimized gene delivery methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Overexpression of human methylmalonyl CoA mutase in mice after in vivo gene transfer with asialoglycoprotein/polylysine/DNA complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

The contribution of poly-L-lysine, epidermal growth factor and streptavidin to EGF/PLL/DNA polyplex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

A stable system for the high-titer production of multiply attenuated lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Arteriogenic gene therapy in patients with unreconstructable critical limb ischemia: a randomized, placebo-controlled clinical trial of adenovirus 5-delivered fibroblast growth factor-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Adeno-associated virus: from defective virus to effective vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Sustained whole-body functional rescue in congestive heart failure and muscular dystrophy hamsters by systemic gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Kinetics of recombinant adeno-associated virus-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

Molecular Biology, Eugenics and Euphenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2013.818813

10.1586/14779072.2013.818813

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference